Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FE1FU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,697
Award facts
- Contract value 100% obligated
- $16,696.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,696.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens on September 26, 2025, with completion expected by September 29, 2025. This non-set-aside competitive award represents a child delivery order executed under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical product being delivered supports military healthcare programs, as Dupixent is a specialty biologic medication used to treat conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the federal medical supply chain, with the place of performance designated at its corporate office location.
AmerisourceBergen's SPE2DX prime vendor contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply brand-name and generic medications, specialty drugs, vaccines, and medical supplies to military healthcare systems and the Defense Health Agency. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through competitive, open competition processes. This delivery order exemplifies the operational execution of the larger strategic contract vehicle, allowing DLA to procure specialized pharmaceutical products on an as-needed basis to support military medical readiness and healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DB25FE1FU?
SPE2DB25FE1FU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FE1FU worth?
The government has obligated $16,697 on SPE2DB25FE1FU.
Is contract SPE2DB25FE1FU an order under another contract?
Yes. SPE2DB25FE1FU is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE1FU competed?
The extent of competition for SPE2DB25FE1FU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award